Work

Phase II clinical trial of olaparib plus pembrolizumab in the treatment of patients with advanced biliary tract cancer.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.4087

Authors: James O'Bryan, Chao Yin, Benjamin Adam Weinberg, Marcus Smith Noel, Reetu Mukherji, Monika Kulasekaran, Seema Agarwal, Gary Kupfer, Hongkun Wang, Marion L. Hartley, John Marshall, Aiwu Ruth He, ASCO Authors' Group

Institutions: MedStar Georgetown University Hospital, MedStar Harbor Hospital, Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Merck

OpenAlex ID: W4379282889

Cites:

Cited by: 5

Related to: 10